Our strategic academic partner is the University of Pittsburgh School of Medicine. The University of Pittsburgh School of Medicine celebrated its 125th anniversary in 2012 and shares Nazarbayev University School of Medicine’s goal of educating physicians who are science-based, skilled, and compassionate clinicians prepared to meet the challenges of practicing medicine in the 21st century and conducting cutting-edge research that is focused on bettering the human condition and advancing the fundamental understanding of medical science. The school is among the top ten in the United States in biomedical research funding from the National Institutes of Health, and its graduating physicians consistently perform well on the United States Medical Licensing Examination (USMLE) and move on to top residency training programs in virtually all medical specialty areas. The school is well known historically for the development of the first safe, effective vaccine against polio by Dr. Jonas Salk and his team of scientists and, more recently, for pioneering the advancement of organ transplantation as a viable clinical entity and for brain-computer interface technology that may, one day, enable people with paralyzing conditions to control robotic limbs with their brain signals alone.
For more information about the University of Pittsburgh School of Medicine, please click here.